Back to CRL
Assenagon Asset Management S.A. → CRL
Assenagon Asset Management S.A. CRL Position History
Charles River Laboratories International, Inc. • Healthcare
Quarters held
6
Latest value
$58.6M
Q3 2026
Peak value
$58.6M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $5.1M |
| Q4 2025 | $13.1M |
| Q1 2026 | $3.8M |
| Q2 2026 | $14M |
| Q2 2026 | $14M |
| Q3 2026 | $58.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $58.6M | 198.7K | — | — |
| Q2 2026 | $14M | 61.8K | — | — |
| Q2 2026 | $14M | 61.8K | — | — |
| Q1 2026 | $3.8M | 22.2K | — | — |
| Q4 2025 | $13.1M | 65.9K | — | — |
| Q3 2025 | $5.1M | 32.3K | — | — |
Other funds holding CRL
$508.3M
$422.8M
$422.8M
$371.4M
$362.1M
$334.6M
$328.4M
$323.2M